Cargando…
Therapeutic potential of bacteriophage endolysins for infections caused by Gram-positive bacteria
Gram-positive (G(+)) bacterial infection is a great burden to both healthcare and community medical resources. As a result of the increasing prevalence of multidrug-resistant G(+) bacteria such as methicillin-resistant Staphylococcus aureus (MRSA), novel antimicrobial agents must urgently be develop...
Autores principales: | Liu, He, Hu, Zhen, Li, Mengyang, Yang, Yi, Lu, Shuguang, Rao, Xiancai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10131408/ https://www.ncbi.nlm.nih.gov/pubmed/37101261 http://dx.doi.org/10.1186/s12929-023-00919-1 |
Ejemplares similares
-
Antibacterial Activity of Stenotrophomonas maltophilia Endolysin P28 against both Gram-positive and Gram-negative Bacteria
por: Dong, Hongling, et al.
Publicado: (2015) -
Current Status of Endolysin-Based Treatments against Gram-Negative Bacteria
por: Gontijo, Marco Túlio Pardini, et al.
Publicado: (2021) -
Characterization of Three Different Endolysins Effective against Gram-Negative Bacteria
por: Jeong, Tae-Hwan, et al.
Publicado: (2023) -
A bacteriophage endolysin that eliminates intracellular streptococci
por: Shen, Yang, et al.
Publicado: (2016) -
Bacteriophage endolysins as a potential weapon to combat Clostridioides difficile infection
por: Mondal, Shakhinur Islam, et al.
Publicado: (2020)